- Agriculture biotech providing natural organic biopesticide, alternative solution to banned synthetic chemicals.
- Company focused on high-value crops in North, South American market with view to expanding.
- MGRO delivers unique product larger producers failed to deliver, offers robust growth potential
MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) COO Colin Bletsky was featured in a recent SmallCap-Investor interview (https://ibn.fm/Ax1Bd). During the interview, Bletsky discussed the company and its unique value proposition and ambitious plans for the future. MustGrow is an innovative agriculture biotech company providing natural, science-based biological solutions to replace synthetic chemicals used in high-value crops such as fruit and vegetables.
In his comments, Bletsky explained that a rigorous scientific process stands behind the company’s technology. According to Bletsky, MustGrow has invested more than $10 million dollars developing its proprietary technology. The company has also conducted an estimated 110 studies in the field and worked with third-party companies. This significant investment of time and money has led to around 100 of the patents MustGrow now owns.
Although a result of cutting-edge scientific research, MustGrow’s end product comes from nature; it is organic and natural, Bletsky said MustGrow Biologics is open to partnerships with both big players and mid-size companies in the marketplace, which is increasingly trying to gain access to this novel technology. Bletsky believes that although the company is a threat to conventional chemical producers, it also represents an excellent partnership opportunity.
“We are potentially a partner to any one of those companies because we provide a solution that they don’t have right now,” he said. “We have a lot of field data and study showing that we can compete on efficacy and on consistency, and when we look at the marketplaces we’re targeting, we can actually compete on price.”
As consumers and growers demand healthier, safer and easier-to-use alternatives, chemical products are attracting more scrutiny, with countries continuing to deregister some of them. “When we look at everything down the road, we do believe that we have a good opportunity with or without those chemical companies working with us. Even if they’re working against us, we have a unique position,” Bletsky observed.
Although currently focused on higher-value crops where many chemistries are being banned or deregistered in some parts of the world, Bletsky also confirmed that MustGrow is looking into expanding coverage to include potatoes, onions, garlic, bananas and pulses such as chickpeas and lentils.
With an existing registration for the granulated formulation in the United States and Canada, MustGrow Biologics shifts the focus to the second-stage product, liquid-based formulation. The company is in the process of registration with relevant authorities in North America and South America, which Bletsky expects to be completed in 2021; the intended registration process in Europe may take longer due to regulation, he added.
As a tightly held company with 22 out of 37 million outstanding shares held by MustGrow management and advisors, and a small market capitalization ranging from $13 to $15 million, Bletsky believes that MustGrow Biologics offers a unique advantage to investors. Confident that a lot of opportunity exists in the targeted $65 billion pesticide market, of which the fruit and vegetable market is roughly half, he believes the company is ready to start on the path of rapid growth.
For more information, visit the company’s website at www.MustGrow.ca.
NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
InvestorWire is part of the InvestorBrandNetwork.